← Back to Search

Transcranial Magnetic Stimulation During Cognitive Tasks for Healthy Subjects

Phase 4
Recruiting
Led By Alik Widge
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60-300 ms after each tms stimulus
Awards & highlights

Study Summary

This trial will look at whether brain stimulation and cognitive tasks can help improve mental functioning. Participants will do tasks while receiving transcranial magnetic stimulation and brain activity will be measured.

Who is the study for?
This trial is for healthy individuals aged between 18 and 65. Participants should not be pregnant, have metal in their head (except dental fillings), diagnosed psychiatric disorders, epilepsy or history of seizures, recent concussions, adverse reactions to TMS/MRI, neurological conditions like stroke or tinnitus, or implanted medical devices.Check my eligibility
What is being tested?
The study tests if engaging in cognitive or perceptual tasks while receiving transcranial magnetic stimulation (TMS) can enhance mental function. It involves two sessions where brain function changes are measured with EEG during the application of TMS.See study design
What are the potential side effects?
While side effects are rare for TMS when used on healthy subjects, they may include discomfort at the stimulation site, headache, lightheadedness, and a very low risk of seizure.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60-300 ms after each tms stimulus
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60-300 ms after each tms stimulus for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Cortical excitability
Theta-gamma cross frequency coupling

Trial Design

1Treatment groups
Experimental Treatment
Group I: Healthy controlExperimental Treatment1 Intervention
All participants receive the same procedures

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,381 Previous Clinical Trials
1,588,950 Total Patients Enrolled
Alik WidgePrincipal InvestigatorUniversity of Minnesota

Media Library

Healthy control Clinical Trial Eligibility Overview. Trial Name: NCT05962385 — Phase 4
Healthy Subjects Research Study Groups: Healthy control
Healthy Subjects Clinical Trial 2023: Healthy control Highlights & Side Effects. Trial Name: NCT05962385 — Phase 4
Healthy control 2023 Treatment Timeline for Medical Study. Trial Name: NCT05962385 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who would qualify to participate in this medical research?

"This medical trial is seeking healthy patients aged between 18 and 65. Up to 25 individuals can participate in the study."

Answered by AI

Are participants over the age of seventy being accepted into this clinical investigation?

"This clinical trial has established boundaries wherein potential participants must be within 18 to 65 years old. Patients below the age of 18 have 55 different trials they can participate in, whereas those over 65 are eligible for 381 other studies."

Answered by AI

What potential risk factors should be considered when using Healthy Control?

"The safety profile of Healthy control is rated as a 3 according to Power's internal scale, given that it has been approved in Phase 4 clinical trials."

Answered by AI

Are individuals currently being recruited for this investigation?

"According to the data hosted on clinicaltrials.gov, recruitment for this medical study has already concluded despite being posted as recent as August 1st 2023 and updated July 24th 2023. Although no longer open for applications, there are 809 other trials that do still require participants at present."

Answered by AI

Who else is applying?

What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

~15 spots leftby Apr 2025